Figure 1.
Specific targeting of prostate cancer cells with hybrid ELP/liposome nanoparticles.
Notes: Lipids were used to generate various types of DTX-encapsulating liposomes, which were mixed with recombinant ELPs to form self-assembled nanoparticles at raised temperature. The use of ELP-GRP fusion proteins increased specific binding to GRPR expressing prostate cancer cells and showed enhanced cytotoxic effects.
Abbreviations: DTX, docetaxel; ELP, elastin-like polypeptide; GRP, gastrin-releasing peptide; GRPR, gastrin-releasing peptide receptor.